$AQSZF News
Last published 3y ago
- 3y agoAQSZFAequus Reports Second Quarter 2023 Financial Highlights and General UpdateGlobeNewswireVANCOUVER, British Columbia, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing,
- 3y agoAQSZFAequus Announces Zimed PF Now Available in CanadaGlobeNewswireVANCOUVER, British Columbia, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF), ) ("Aequus" or the "Company"), a specialty pharmaceutical company announced today, we are thrilled to
- 3y agoAQSZFAequus Announces Zimed PF Website LaunchGlobeNewswireVANCOUVER, British Columbia, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF), ) ("Aequus" or the "Company"), a specialty pharmaceutical company, are thrilled to announce the launch
- 3y agoAQSZFAequus Pharmaceutical Canada Announces a Pause in Sales of Evolve Intensive Eyedrops and Gel in CanadaGlobeNewswireVANCOUVER, British Columbia, Aug. 18, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF), ) ("Aequus" or the "Company"), a specialty pharmaceutical company announces the pause of sales of its
- 3y agoAQSZFAequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%)GlobeNewswireVANCOUVER, British Columbia, July 06, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF) ("Aequus" or the "Company"), announces today it has increased its debt by $400,000 to support the
- 3y agoAQSZFAequus Provides General Update and First Quarter 2023 Financial HighlightsGlobeNewswireVANCOUVER, British Columbia, May 30, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing
- 3y agoAQSZFAequus Provides General Update and Fiscal 2022 Financial ResultsGlobeNewswireVANCOUVER, British Columbia, May 01, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company focused on bringing healthcare solutions
- 3y agoAQSZFAequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%) and Board UpdateGlobeNewswireVANCOUVER, British Columbia, April 05, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF) ("Aequus" or the "Company"), announced today it has entered into a loan agreement to raise $500,000 to
- 3y agoAQSZFAequus Announces Health Canada Notice of Compliance (NOC) for Zimed® Preservative Free (Bimatoprost 0.03%)GlobeNewswireVANCOUVER, British Columbia, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF) ("Aequus" or the "Company"), is pleased to announce that Health Canada has approved Zimed® PF
- 3y agoAQSZFAequus Reports Third Quarter 2022 Financial HighlightsGlobeNewswireVANCOUVER, British Columbia, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing,
- 3y agoAQSZFAequus Announces Sandoz Contract Expiry at Year End and Expected Health Canada Approval for Zimed® PF (Preservative Free)GlobeNewswireVANCOUVER, British Columbia, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF) ("Aequus" or the "Company"), announced today that it has agreed to end its promotional service
- 4y agoAQSZFAequus Reports Second Quarter 2022 Financial Highlights and General UpdateGlobeNewswireVANCOUVER, British Columbia, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing, and promoting differentiated produ
- 4y agoAQSZFAequus Resumes Trading on TSX Venture ExchangeGlobeNewswireVANCOUVER, British Columbia, July 13, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF) announces that further to our news release dated July 6, 2022, we will resume trading on the TSX Venture exchange tomorrow, July 14, 2022
- 4y agoAQSZFAequus Signs Exclusive Distribution Agreement with SCOPE Ophthalmics for Canadian Distribution Rights of Dry Eye ProductsGlobeNewswireVANCOUVER, British Columbia, July 06, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF) ("Aequus" or the "Company") is pleased to announce the signing of an exclusive distribution agreement with SCOPE Ophthalmics. ("SCOPE"),
- 4y agoAQSZFAequus Provides General Update and Reports Record 2021 Financial ResultsGlobeNewswireAlso reports Financial Results for the 3 months ended March 31, 2022 VANCOUVER, British Columbia, July 01, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company
- 4y agoAQSZFAequus Provides Update on Delay in Filing Annual Financial StatementsGlobeNewswireVANCOUVER, British Columbia, June 13, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF) ("Aequus" or the "Company") announces that further to its news release on May 6, 2022 and May 26, 2022, the filing of its audited annual
- 4y agoAQSZFAequus Provides Update on Delay in Filing Annual Financial StatementsGlobeNewswireVANCOUVER, British Columbia, May 27, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF) ("Aequus" or the "Company") announces that further to its news release on May 6, 2022, the filing of its audited annual financial statemen
- 4y agoAQSZFAequus Provides Update on Delay in Filing Annual Financial StatementsGlobeNewswireVANCOUVER, British Columbia, May 06, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF) ("Aequus" or the "Company") announces that further to its news release on May 2, 2022, the filing of its audited annual financial statemen
- 4y agoAQSZFAequus Announces Delay in Filing Annual Financial StatementsGlobeNewswireVANCOUVER, British Columbia, May 02, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF) ("Aequus" or the "Company") announces that the filing of its audited annual financial statements for the fiscal year ended December 31, 20
- 4y agoAQSZFAequus Announces Short Term LoanGlobeNewswireVANCOUVER, British Columbia, May 02, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF) ("Aequus" or the "Company") announces that it has entered into an agreement with Mr. Doug Janzen, Chairman and Chief Executive Officer of
- 4y agoAQSZFAequus Announces Director ResignationGlobeNewswireVANCOUVER, British Columbia, April 22, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announces that Mr. Jaso
- 4y agoAQSZFAequus Extends Commercial Agreement for Specialty Product Tacrolimus IR in CanadaGlobeNewswireVANCOUVER, British Columbia, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF) ("Aequus" or the "Company"), announced today that it has agreed to an extension of terms for its promotional service agreement with Sando
- 4y agoAQSZFAequus Announces Canadian Filing of NDS for Preservative-Free Glaucoma MedicationGlobeNewswireHealth Canada Submission of Preservative-Free Prescription ‘Zimed PF' Accepted for Screening VANCOUVER, British Columbia, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF), ) ("Aequus" or the "Company"), a speci
- 5y agoAQSZFAequus Reports Third Quarter 2021 Financial HighlightsGlobeNewswireVANCOUVER, British Columbia, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated produc
- 5y agoAQSZFAequus Reports Second Quarter 2021 Financial HighlightsGlobeNewswireVANCOUVER, British Columbia, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated produc
- 5y agoAQSZFAequus Strengthens Clinical Experience in Stargardt Disease with Pediatric Ophthalmology ExpertiseGlobeNewswireVANCOUVER, British Columbia, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF) ("Aequus") a speciality pharmaceutical company, is pleased to announce that Dr. Robert K. Koenekoop MD, MSc, PhD, FRCS(C), FARVO�
- 5y agoAQSZFAequus and reVision to Collaborate on Stargardt Disease ProgramPR NewswireVANCOUVER, BC and RIDGEWOOD, N.J., Aug. 17, 2021 /PRNewswire/ -- Aequus Pharmaceuticals Inc. (TSXV:AQS) (OTCQB:AQSZF) ("Aequus") and reVision Therapeutics, Inc. ("reVision") announce a collaboration on the development of a therapy for Stargardt disease.
- 5y agoAQSZFAequus and reVision to Collaborate on Stargardt Disease ProgramGlobeNewswireVANCOUVER, British Columbia and RIDGEWOOD, N.J., Aug. 17, 2021 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF) ("Aequus") and reVision Therapeutics, Inc. ("reVision") announce a collaboration on the development of a therapy for
- 5y agoALPPAMYZFAQSZFASDRF+16Proactive news headlines including Marble Financial, Vuzix Corp, Talon Metals and UnigoldGlobeNewswireNew York, June 09, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: Vuzix Corporation (NASDAQ:VUZI) rises to the ranks of the
- 5y agoAQSZFAequus Provides Commercial UpdateGlobeNewswireVANCOUVER, British Columbia, June 09, 2021 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated produc
- 5y agoAQSZFAequus Provides General Update and First Quarter 2021 Financial HighlightsGlobeNewswireVANCOUVER, British Columbia, May 31, 2021 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated product
- 5y agoAQSZFAUIAFBRGGFCYDY+6Proactive North America headlines including Tetra Bio-Pharma, Naturally Splendid Entrerprises, Energy Fuels, FansUnite Entertainment and CytoDynGlobeNewswireNew York, April 23, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: Real Luck Group cheers House of Commons passing of b
- 5y agoAQSZFAequus Provides General Update and Reports Record 2020 Financial ResultsGlobeNewswireVANCOUVER, British Columbia, April 23, 2021 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated produ
- 5y agoAQSZFAequus to Present at the 2021 Bloom Burton & Co. Healthcare Investor ConferenceGlobeNewswireVANCOUVER, British Columbia, April 19, 2021 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX:AQS, OTCQB:AQSZF), a Canadian based specialty pharmaceutical company, will be presenting at the 2021 Bloom Burton & Co. Healthcare Investor Conference. Cha